Table 3.
Presenting treatment of deceased and recovered patients with COVID-19.
| Treatment | No. (%) | P Valuea | ||
|---|---|---|---|---|
| Total (N=836) | Deceased (n=199) | Survivors (n=637) | ||
| Oxygen therapy | 733 (87.7) | 137 (100) | 600 (85.8) | <0.001 |
| Noninvasive mechanical ventilation | 157 (19.0) | 114 (83.8) | 43 (6.2) | <0.001 |
| Invasive mechanical ventilation | 64 (7.7) | 62 (45.6) | 2 (0.3) | <0.001 |
| CRRT | 2 (0.2) | 2 (1.5) | 0 (0.0) | 0.001 |
| ECMO | 6 (0.7) | 5 (3.7) | 1 (0.1) | <0.001 |
| Systemic corticosteroids therapy | 400 (47.8) | 105 (78.4) | 295 (42.8) | <0.001 |
| Intravenous immunoglobin | 216 (25.8) | 67 (49.3) | 149 (21.5) | <0.001 |
| Anti-viral drug | 765 (91.5) | 95 (69.3) | 670 (95.9) | <0.001 |
| Antibiotic drug | 702 (84.0) | 130 (94.9) | 572 (81.8) | <0.001 |
Data are presented as n/N (%), where N is the total number of patients with available data. CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation.
aP value indicate differences between deceased and recovered patients. P < 0.05 was considered statistically significant.